Trends in Cutaneous Melanoma in Nova Scotia With a Focus on 2007 to 2019
Journal of Cutaneous Medicine and Surgery · 2025
DOI: 10.1177/12034754241301404 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cutaneous Medicine and Surgery, 2025. Verfasst von Rachel A Dorey und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Dalhousie University, Halifax, NS, Canada. Hauptthemen laut MEDLINE: Melanoma, Skin Neoplasms. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dalhousie Medical Research Foundation Bergmann-Porter Studentship.
Abstract (Originalsprache)
Background
Melanoma represents a significant public health challenge in Canada, contributing to the deaths of over 1000 individuals each year. Prince Edward Island and Nova Scotia were previously noted to have the highest incidence rates of melanoma in Canada.
Methods
Data from patients diagnosed with or dying from melanoma was extracted from the Nova Scotia Cancer Registry. TNM stage was available for cases diagnosed 2007 to 2017. Incidence (1992-2019) and mortality (1992-2021) rates were examined using Join Point Trend Analysis Software.
Results
Between 2007 and 2019, 2450 cases of in situ and 4063 cases of invasive melanoma were documented, of which 52.8% were male. The largest number of cases was from the 60- to 79-year age group. The most common site in females was upper limbs (in situ) and lower limbs (invasive), and for males, face, and neck (in situ), and trunk (invasive). The majority of invasive cases (71.5%) were diagnosed at stage I. Invasive melanoma incidence has been increasing by 2.7% per year since 1992, while in situ disease has increased at a greater rate (4.9% per year). The current estimate of 92% for 5 years of net survival has not changed appreciably over the same period. Survival for late-stage melanoma has shown a modest improvement for patients diagnosed over the period.
Conclusion
With increasing rates of melanoma in Nova Scotia, there is a need for informed education, directed at the public and physicians, around pigmented skin lesions. This would allow the patient to detect atypical melanocytic lesions at an early stage. Sun safety practices in Nova Scotia should continue to be encouraged.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Medicine, Dalhousie University, Halifax, NS, Canada.
- Nova Scotia Health Cancer Care Program, Halifax, NS, Canada.
- Division of Clinical Dermatology and Cutaneous Science, Department of Medicine, Dalhousie University, Halifax, NS, Canada.
ORCID-Profile: Rachel A Dorey, Peter R Hull
Förderung
- Dalhousie Medical Research Foundation Bergmann-Porter Studentship
Zitieren
APA
Dorey, R. A., Walsh, G., Dewar, R., & Hull, P. R. (2025). Trends in Cutaneous Melanoma in Nova Scotia With a Focus on 2007 to 2019. Journal of Cutaneous Medicine and Surgery. https://doi.org/10.1177/12034754241301404
Vancouver
Dorey RA, Walsh G, Dewar R, Hull PR. Trends in Cutaneous Melanoma in Nova Scotia With a Focus on 2007 to 2019. Journal of Cutaneous Medicine and Surgery. 2025. doi:10.1177/12034754241301404
BibTeX
@article{Dorey2025,
author = {Dorey, Rachel A and Walsh, Gordon and Dewar, Ron and Hull, Peter R},
title = {Trends in Cutaneous Melanoma in Nova Scotia With a Focus on 2007 to 2019},
journal = {Journal of Cutaneous Medicine and Surgery},
year = {2025},
doi = {10.1177/12034754241301404}
}
EUVIMED